CB Issuance Details Amended: New Investor, Dates
애드바이오텍
179530
Signal Score
Historical Avg Return (5d)
+0.00%
Data Coverage
100%n=2589
Risk-adjusted indicator based on 2589 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • New CB Issuance Amount: 3,000,000,000 KRW
- • New Conversion Price: 1,992 KRW/Share
- • New Convertible Shares: 1,506,024 Shares
- • Dilution Rate (New CB): 7.11%
- • Total Potential Dilution (All CBs): 38.98%
AI Analysis Summary
ADBIOTECH Co.,Ltd. has amended its Material Fact Report regarding the issuance of convertible bonds. The key changes include a new investor, 'K-Polaris Investment Association', and revised dates for the bond maturity, subscription, and payment. The new conversion price is 1,992 KRW per share, leading to 1,506,024 potential new shares, representing a 7.11% dilution from this specific CB. The total potential dilution from all outstanding and newly issued convertible bonds is now 38.98% of the current outstanding shares (19,679,630 Shares). This significant potential dilution is a negative factor for existing shareholders.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.